This page contains a Flash digital edition of a book.
Ischemic Stroke—Stenting versus Surgery for Carotid Disease


1. Sacco RL, Kargman DE, Gu Q, Zamanillo MC, Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study, Stroke, 1995;26(1):14–20.


2. Wolff T, Guirguis-Blake J, Miller T, et al., Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force, Ann Intern Med, 2007;147(12):860–70.


3. Wityk RJ, Lehman D, Klag M, et al., Race and sex differences in the distribution of cerebral atherosclerosis, Stroke, 1996;27(11):1974–80.


4. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators, N Engl J Med, 1991;325(7):445–53.


5. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group, Lancet, 1991;337(8752):1235–43.


6. Barnett HJ, Taylor DW, Eliasziw M, et al., Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators, N Engl J Med, 1998;339(20):1415–25.


7. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST), Lancet, 1998;351(9113):1379–87.


8. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study, JAMA, 1995;273(18):1421–8.


9. Halliday A, Mansfield A, Marro J, et al., Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial, Lancet, 2004;363(9420):1491–502.


10. Halliday A, Harrison M, Hayter E, et al., 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial, Lancet, 2010;376(9746):1074–84.


11. Alamowitch S, Eliasziw M, Algra A, et al., Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis, Lancet, 2001;357(9263):1154–60.


12. Rothwell PM, Gutnikov SA, Warlow CP, Reanalysis of the final results of the European Carotid Surgery Trial, Stroke, 2003;34(2):514–23.


13. Rothwell PM, Eliasziw M, Gutnikov SA, et al., Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis, Lancet, 2003;361(9352):107–16.


14. Gorelick PB, Carotid endarterectomy : where do we draw the line?, Stroke, 1999;30(9):1745–50.


15. Goldstein LB, Moore WS, Robertson JT, Chaturvedi S, Complication rates for carotid endarterectomy. A call to action, Stroke, 1997;28(5):889–90.


16. Rothwell PM, Eliasziw M, Gutnikov SA, et al., Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery, Lancet, 2004;363(9413):915–24.


17. Kernan WN, Viscoli CM, Brass LM, et al., The stroke prognosis instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke, Stroke, 2000;31(2):456–62.


18. Gasecki AP, Eliasziw M, Ferguson GG, et al., Long-term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: results from NASCET. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group, J Neurosurg, 1995;83(5):778–82.


19. Rothwell PM, Mehta Z, Howard SC, et al., Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy, Lancet, 2005;365(9455):256–65.


20. Brott TG, Brown RD Jr, Meyer FB, et al., Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting, Mayo Clin Proc, 2004;79(9):1197–208.


21. Ringleb PA, Allenberg J, Brückmann H, et al., 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial, Lancet, 2006;368(9543):1239–47.


22. Stingele R, Berger J, Alfke K, et al., Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study, Lancet Neurol, 2008;7(3):216–22.


23. Eckstein HH, Ringleb P, Allenberg JR, et al., Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial, Lancet Neurol, 2008;7(10):893–902.


24. Mas JL, Chatellier G, Beyssen B, et al., Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis, N Engl J Med, 2006;355(16):1660–71.


25. Ederle J, Dobson J, Featherstone RL, et al., Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial, Lancet, 2010;375(9719):985–97.


26. Bonati LH, Jongen LM, Haller S, et al., New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS), Lancet Neurol, 2010;9(4):353–62.


27. Roffi M, Sievert H, Gray WA, et al., Carotid artery stenting versus surgery: adequate comparisons?, Lancet Neurol, 2010;9(4):339–41; author reply 341–2.


28. Fiehler J, Bakke SJ, Clifton A, et al., Plea of the defence-critical comments on the interpretation of EVA3S, SPACE and ICSS,


Neuroradiology, 2010;52(7):601–10.


29. Fiehler J, Jansen O, Berger J, et al., Differences in complication rates among the centres in the SPACE study, Neuroradiology, 2008;50(12):1049–53.


30. Macdonald S, Lee R, Williams R, Stansby G, Delphi Carotid Stenting Consensus Panel, Towards safer carotid artery stenting: a scoring system for anatomic suitability, Stroke, 2009;40(5):1698–703.


31. Brott TG, Hobson RW 2nd, Howard G, et al., Stenting versus endarterectomy for treatment of carotid-artery stenosis, N Engl J Med, 2010;363(1):11–23.


32. Silver FL, Mackey A, Clark WM, et al., Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST), Stroke, 2011;42(3):675–80.


33. Howard VJ, Lutsep HL, Mackey A, et al., Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), Lancet Neurol, 2011;10(6):530–7.


34. Abbott AL, Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis, Stroke, 2009;40(10):e573–83.


35. Hirt LS, Progression Rate and Ipsilateral Neurological Events in Asymptomatic Carotid Stenosis, Stroke, 2011 [Epub ahead of print].


36. Markus HS, King A, Shipley M, et al., Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study, Lancet Neurol, 2010;9(7):663–71.


37. Yadav JS, Wholey MH, Kuntz RE, et al., Protected carotid-artery stenting versus endarterectomy in high-risk patients, N Engl J Med, 2004;351(15):1493–501.


38. Yadav JS, Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial, Cleve Clin J Med, 2004;71(Suppl. 1):S45–6.


39. Cambria RP, Stenting for carotid-artery stenosis, N Engl J Med, 2004;351(15):1565–7.


40. Usman AA, Tang GL, Eskandari MK, Metaanalysis of procedural stroke and death among octogenarians: carotid stenting versus carotid endarterectomy, J Am Coll Surg, 2009;208(6):1124–31.


41. Furie KL, Kasner SE, Adams RJ, et al., Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 2011;42(1):227–76.


42. Goldstein LB, Bushnell CD, Adams RJ, et al., Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 2011;42(2):517–84.


US NEUROLOGY


125


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108